JO
AVXL icon

John Overdeck’s Anavex Life Sciences AVXL Stock Holding History

John Overdeck’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.89M Sell
3,046,538
-201,350
-6% -$596K 0.01% 1710
2026
Q1 		$9.97M Buy
3,247,888
+1,594,192
+96% +$6.9M 0.01% 1411
2025
Q4 		$5.89M Buy
1,653,696
+616,742
+59% +$3.78M 0.01% 1564
2025
Q3 		$9.23M Buy
1,036,954
+63,685
+7% +$646K 0.01% 1008
2025
Q2 		$8.97M Buy
973,269
+113,171
+13% +$966K 0.02% 876
2025
Q1 		$7.38M Buy
860,098
+83,197
+11% +$786K 0.02% 912
2024
Q4 		$8.34M Sell
776,901
-53,723
-6% -$413K 0.02% 844
2024
Q3 		$4.72M Sell
830,624
-182,259
-18% -$1.05M 0.01% 1121
2024
Q2 		$4.27M Buy
1,012,883
+477,336
+89% +$1.93M 0.01% 1080
2024
Q1 		$2.73M Buy
535,547
+489,046
+1,052% +$2.75M 0.01% 1282
2023
Q4 		$433K Sell
46,501
-82,515
-64% -$568K ﹤0.01% 2537
2023
Q3 		$845K Buy
129,016
+12,716
+11% +$101K ﹤0.01% 2030
2023
Q2 		$946K Sell
116,300
-143,730
-55% -$1.23M ﹤0.01% 1972
2023
Q1 		$2.23M Buy
260,030
+115,258
+80% +$1.15M 0.01% 1321
2022
Q4 		$1.34M Buy
144,772
+1,986
+1% +$21.2K ﹤0.01% 1550
2022
Q3 		$1.47M Buy
142,786
+63,216
+79% +$667K 0.01% 1290
2022
Q2 		$796K Sell
79,570
-37,263
-32% -$353K ﹤0.01% 1639
2022
Q1 		$1.44M Buy
+116,833
New +$1.44M ﹤0.01% 1504

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

John Overdeck's AVXL Position: Q2 2026 in Review

John Overdeck reduced its Anavex Life Sciences (AVXL) stake by 6.2% in Q2 2026, selling an estimated $596K and leaving 3,046,538 shares worth $7.89M. The position accounts for 0.01% of the portfolio, ranked #1710.

John Overdeck first reported a position in AVXL in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.97M in Q1 2026. 177 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • John Overdeck held 3,046,538 shares of Anavex Life Sciences worth $7.89M as of Q2 2026.
  • John Overdeck sold 201,350 Anavex Life Sciences shares in Q2 2026, an estimated $596K.
  • Anavex Life Sciences made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1710 holding.
  • John Overdeck first reported a position in Anavex Life Sciences in Q1 2022 and has held it in 18 quarters since.
  • John Overdeck's Anavex Life Sciences position peaked at $9.97M in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.